The Miller Group Becomes Major Sponsor of Pepperdine Private Capital Markets Report
Apr 03, 2018 20:07 pm UTC| Business
SCOTTSDALE, Ariz., April 03, 2018 -- The Miller Group (TMG) announced today it is proud to be the Platinum Sponsor of the Pepperdine Graziadio Business School 2018 Private Capital Markets Report prepared by Craig R....
Aehr Test Systems Reports 176% Revenue Growth Year over Year in Third Quarter of Fiscal 2018
Apr 03, 2018 20:06 pm UTC| Business
FREMONT, Calif., April 03, 2018 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced financial results for its third quarter of fiscal 2018 ended February...
Dave & Buster’s Delivers Fourth Consecutive Year of Record Performance
Apr 03, 2018 20:05 pm UTC| Business
DALLAS, April 03, 2018 -- Dave Buster's Entertainment, Inc., (NASDAQ:PLAY), ("Dave Buster's" or "the Company"), an owner and operator of entertainment and dining venues, today announced financial results for its...
Werner Enterprises Announces Upcoming Release of First Quarter 2018 Earnings
Apr 03, 2018 20:05 pm UTC| Business
OMAHA, Neb., April 03, 2018 -- Werner Enterprises, Inc. (NASDAQ:WERN), one of the nation’s largest transportation and logistics companies, announced today that it will release its first quarter 2018 earnings on...
Apr 03, 2018 20:05 pm UTC| Business
FREMONT, Calif., April 03, 2018 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced it has received a $1.5 million follow-on order from a leading...
Charles & Colvard to Present at Investor Conferences in April 2018
Apr 03, 2018 20:05 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., April 03, 2018 -- Charles Colvard, Ltd. (Nasdaq:CTHR), the original and leading worldwide source of created moissanite, announced that Suzanne Miglucci, President and CEO, and Clint J....
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Apr 03, 2018 20:05 pm UTC| Business
WAYNE, Pa., April 03, 2018 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to...